• Lactate as a Metabolic Signal in Cancer Research

  2026-09-22

  Lactate is more than a glycolytic endpoint: it can connect tumor metabolism with immune regulation. This article explains how to distinguish lactate production from lactate-driven signaling and design assays around the NAT1–ENO1–lactate–PD-L1 axis.

• How Fasting Rewires Translation in Tumorigenesis

  2026-09-22

  The reference study identifies an AMPK–MNK–eIF4E signaling axis through which elevated fatty acids during fasting or a ketogenic diet selectively remodel hepatic translation while overall protein synthesis declines. Its findings connect diet-dependent ketogenesis to pancreatic tumor growth and suggest that translational control, rather than transcription alone, can provide a therapeutic vulnerability.

• RSL3 Workflow for GPX4-Driven Ferroptosis

  2026-09-21

  RSL3 provides a direct way to test whether GPX4-dependent redox buffering controls lipid peroxidation and cell survival. This practical workflow connects dose-response profiling, ferroptosis rescue, oncogenic RAS comparisons, and insights from a peripheral nerve injury study without overstating preclinical evidence.

• Propranolol and Emotional Memory: Meta-analysis

  2026-09-21

  This meta-analysis synthesized randomized, double-blind evidence that propranolol can reduce later recall of negatively valenced material when administered before memory consolidation or reconsolidation. Its main contribution is to distinguish a reproducible effect in healthy adults from the much larger question of whether experimentally weakened emotional memories can produce durable clinical benefit.

• Vitamin C in ROS-Driven Cell Senescence Assays

  2026-09-20

  Build a controlled ascorbic acid workflow for modeling oxidative-stress senescence in HEI-OC1 cochlear cells, while preserving a separate dose strategy for tumor studies. The guide connects pathway-focused validation with practical handling, orthogonal endpoints, and troubleshooting for cancer research and translational redox assays.

• Exo1 Workflow for Membrane Trafficking Studies

  2026-09-19

  Exo1 enables acute, mechanism-focused inhibition of exocytosis for Golgi, ER, and ARF1 experiments. This guide translates its distinct activity into practical exocytosis assay workflows while separating validated product properties from exploratory applications in extracellular-vesicle research.

• GKT137831 for Reliable Cell Assays

  2026-09-18

  A scenario-driven guide to using GKT137831 (SKU B4763) in cell viability, proliferation, cytotoxicity, and oxidative-stress workflows. It connects dose selection, solvent control, ROS interpretation, ferroptosis context, and supplier evaluation to practical laboratory decisions.

• TMEM16F, Ferroptosis, and Tumor Immune Rejection

  2026-09-18

  Yang et al. identify TMEM16F-mediated phospholipid scrambling as a late membrane-protective mechanism that limits ferroptotic plasma membrane failure. Disrupting this pathway increases lytic death, danger-signal release, tumor control, and responsiveness to PD-1 blockade, providing a mechanistic link between ferroptosis execution and antitumor immunity.

• Vitamin C in ROS-Driven Senescence Assays

  2026-09-17

  Build a redox-aware HEI-OC1 senescence workflow with ascorbic acid, matched controls, and orthogonal readouts instead of relying on viability alone. The same product also supports carefully separated cancer research applications, where dose and cellular context determine whether Vitamin C behaves as a protective perturbation or an anticancer agent.

• VEGFC–VEGFR-3 Signaling in NASH Fibrosis

  2026-09-17

  This Phytomedicine study identifies a hepatocyte-derived VEGFC–VEGFR-3 and CCL2/CCR2 regulatory axis that promotes inflammatory macrophage recruitment and sustains high-fat diet-induced hepatic fibrosis. By combining pharmacological inhibition, hepatocyte-specific Vegfc deletion, patient data, and hepatocyte–macrophage co-culture models, the work positions VEGFR-3 signaling as a mechanistic target for investigating NASH-associated fibrosis.

• Fasudil (HA-1077) HCl: ROCK Workflow Guide

  2026-09-16

  Fasudil (HA-1077) HCl provides a practical chemical-probe strategy for Rho/ROCK pathway inhibition, with applications spanning cell migration, proliferation, and apoptosis assays. This workflow also shows how to connect ROCK perturbation with Hippo-pathway readouts without overstating evidence from cataract models.

• Glucocorticoids, Kv2.1, and CaV1.2 Calcium Signals

  2026-09-16

  This 2024 Journal of Neuroscience study identifies a rapid, non-genomic mechanism by which glucocorticoids suppress CaV1.2-mediated calcium signals in hippocampal neurons. The work links reduced cAMP–PKA activity to endocytosis of Kv2.1 channel clusters, revealing how membrane organization—not only channel gating—controls acute glucocorticoid effects in the brain.

• IAM LC vs LEKC for Pulmonary Permeability

  2026-09-15

  This reference study provides a direct biomimetic comparison of immobilised artificial membrane liquid chromatography and liposome electrokinetic capillary chromatography for drug–membrane partitioning and pulmonary permeability assessment. LEKC more closely reflected apparent lung permeability by capturing hydrophobic and electrostatic interactions, whereas IAM LC offered broader compound coverage and simpler, more automation-ready analysis.

• Reframing CYP2C19 Studies with (S)-Mephenytoin

  2026-09-15

  How (S)-Mephenytoin can connect CYP2C19 enzymology with hiPSC-derived intestinal organoids to improve mechanistic pharmacokinetic studies and translational decision-making.

• RCN2, PPP2CA, and Cisplatin Resistance in ESCC

  2026-09-14

  This study identifies RCN2 as a driver of esophageal squamous cell carcinoma metastasis and cisplatin resistance through UBR5-dependent degradation of PPP2CA. Its integrated molecular, biochemical, cellular, and animal-model evidence places the RCN2–PPP2CA–PI3K-AKT axis at the center of a potentially actionable resistance mechanism.

3625 records 1/242 page Next 12345 下5页 Last page